Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

IL-15 helps maintain hair growth and protects the immune status of hair follicles.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.

A young woman recovered well from rare simultaneous Hepatitis B and autoimmune hepatitis after treatment.

i-PRF and A-PRF are promising treatments for hair regrowth in androgenetic alopecia.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Ruxolitinib helped a patient with alopecia areata regrow hair.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Baricitinib is effective and safe for treating severe alopecia areata.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

A woman with a skin disorder was found to have hepatitis C, which may be linked, and was safely treated with methotrexate.

Anifrolumab improves quality of life and reduces steroid use in lupus patients.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Hydroxychloroquine may cause false results in tuberculosis tests for patients with autoimmune skin diseases.

Combining delgocitinib ointment with excimer laser can effectively treat severe alopecia areata.

IVIG therapy was linked to hair regrowth in two patients with hair loss, but it's not recommended due to its risks and costs.

Both treatments improved hair quality and thickness equally, with mild side effects.

Aromatase inhibitors can cause various adverse reactions, so monitoring is crucial.

Low-dose intralesional corticosteroid treatment led to rapid hair regrowth in localized alopecia areata.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

JAK inhibitors like tofacitinib can effectively treat severe alopecia areata.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

The combination therapy may be more effective for mild alopecia areata, especially in patients with allergies.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

Membership in a self-help organization is linked to being better informed and having a higher education, but it doesn't clearly affect disease outcomes.